Skip to main content
HairCited

Minoxidil para Pérdida Capilar de Patrón Femenino

A

Basado en 67 estudios (4 meta-analyses, 11 RCTs) con 28,815 participantes en total. 53/67 estudios muestran efectos positivos.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusión

Research strongly suggests that minoxidil may help women with female pattern hair loss regain hair density, supported by numerous high-quality clinical trials.

  • 67 studies including 11 RCTs and 4 meta-analyses specifically in women
  • 79% of studies report positive effects on hair growth
  • Low-dose oral minoxidil is emerging as a well-tolerated alternative to topical application
  • Combination with other ingredients like spironolactone may enhance results

Key Study Findings

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Efecto: None None

Población: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss Efecto: None None

Población: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo Efecto: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None
narrative review
Addressing the Root Causes of Female Hair Loss and Non-Pharmaceutical Interventions.
Dose: None vs: Placebo Efecto: None None
randomized controlled trial n=45 16 weeks Open-label
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in …
Dose: Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi vs: Placebo Efecto: Groups A and C showed significant improvement on Sinclair scale and trichoscopic hair density; Group None
Review
Male and female pattern hair loss.
Dose: None vs: Placebo Efecto: None None

Key Statistics

111

Estudios

37800

Participantes

Positive

A

Calificación

Referenced Papers

Australian prescriber 2025 2 citas
Annals of dermatology 2025
SAGE open medical … 2024 3 citas
Drugs 2023 221 citas
Anais brasileiros de … 2023 29 citas
Journal of cosmetic … 2023 3 citas
The Journal of … 2022 170 citas
Faculty reviews 2022 44 citas
Journal of cosmetic … 2022 7 citas
Journal of the … 2021 42 citas
International journal of … 2020 58 citas
Indian dermatology online … 2020 31 citas
Australian journal of … 2018 8 citas
JAMA dermatology 2017 121 citas
The Cochrane database … 2016 18 citas
World journal of … 2015 62 citas
Seminars in cutaneous … 2015 20 citas
Clinical obstetrics and … 2015 9 citas
Current problems in … 2015 8 citas
Skin therapy letter 2014 29 citas
Dermatologic clinics 2013 78 citas
International journal of … 2013 61 citas
Indian journal of … 2013 16 citas
International journal of … 2013
The Cochrane database … 2012 15 citas
Skinmed 2012 5 citas
Seminars in cutaneous … 2009 4 citas
American family physician 2009
Journal of the … 2008 290 citas
Clinical interventions in … 2007
Duodecim; laaketieteellinen aikakauskirja 2006
The British journal … 2005 205 citas
The journal of … 2003 102 citas
Clinical and experimental … 2002 61 citas
Therapeutische Umschau. Revue … 2002 4 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

topical:
2-5% solution, twice daily

Límite superior: 5% topical solution

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
varies by agent and study -- Positive --
None -- Positive --
Group A: topical finasteride 1% solution; Group B: topical spironolactone 5% solution; Group C: topi 16 weeks Positive 45
None -- Positive --
Spironolactone 100 mg once daily 24 weeks Positive 48
None -- Positive --

Mejor momento para tomar: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Efectos secundarios reportados

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interacciones conocidas

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Ingesta máxima tolerable: 5% topical solution

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Minoxidil help with Pérdida Capilar de Patrón Femenino?
Based on 111 studies with 37,800 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Pérdida Capilar de Patrón Femenino management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Pérdida Capilar de Patrón Femenino?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Pérdida Capilar de Patrón Femenino?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 111 peer-reviewed studies with 37,800 total participants. The overall direction of effect is positive.

Related Evidence

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.